These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 945166)

  • 21. Locomotor hyperactivity induced by MK-801 in rats.
    Maj J; Rogóz Z; Skuza G
    Pol J Pharmacol Pharm; 1991; 43(6):449-58. PubMed ID: 1687944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transdihydrolisuride, a partial dopamine receptor antagonist: effects on monoamine metabolism.
    Kehr W
    Eur J Pharmacol; 1984 Jan; 97(1-2):111-9. PubMed ID: 6421606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of dopaminergic receptors in the behavioral effects induced by lisuride in male rats.
    Baggio G; Ferrari F
    Psychopharmacology (Berl); 1983; 80(1):38-42. PubMed ID: 6408668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopamine agonists increase pallidal unit activity: attenuation by agonist pretreatment and anesthesia.
    Bergstrom DA; Bromley SD; Walters JR
    Eur J Pharmacol; 1984 Apr; 100(1):3-12. PubMed ID: 6723776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Terguride, a mixed dopamine agonist-antagonist, in animal models of Parkinson's disease.
    Koller WC; Herbster G
    Neurology; 1987 Apr; 37(4):723-7. PubMed ID: 3561789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopaminergic effects of lergotrile: possible involvement of a metabolite.
    McDevitt JT; Setler PE
    Neuropharmacology; 1980 Jun; 19(6):537-42. PubMed ID: 6105627
    [No Abstract]   [Full Text] [Related]  

  • 27. Locomotor effects of lisuride: a consequence of dopaminergic and serotonergic actions.
    Fink H; Morgenstern R
    Psychopharmacology (Berl); 1985; 85(4):464-8. PubMed ID: 2991961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of ciladopa hydrochloride as a potential anti-Parkinson drug.
    Koller WC; Fields JZ; Gordon JH; Perlow MJ
    Neuropharmacology; 1986 Sep; 25(9):973-9. PubMed ID: 3774130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Suppressive effects of lisuride on the synthesis, release and metabolism of dopamine in rat brain].
    Azuma H; Iwai K; Sato K; Kikuta M; Liu HJ; Oshino N
    Nihon Yakurigaku Zasshi; 1982 Nov; 80(5):325-39. PubMed ID: 6131854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of penfluridol and other drugs on apomorphine-induced stereotyped behavior in monkeys.
    Shintomi K; Yamamura M
    Eur J Pharmacol; 1975 Apr; 31(2):273-80. PubMed ID: 1171014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and central dopaminergic effects of N-(4,6-dimethyl-2-pyridinyl)benzamides.
    Bouhayat S; Piessard S; Le Baut G; Sparfel L; Petit JY; Piriou F; Welin L
    J Med Chem; 1985 May; 28(5):555-9. PubMed ID: 4039368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Role of central catecholamines in the psychostimulant activity of pyrovalerone].
    Fauquet JP; Morel E; Demarty C; Rapin JR
    Arch Int Pharmacodyn Ther; 1976 Dec; 224(2):325-37. PubMed ID: 1035081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding of 3H-lisuride hydrogen maleate to striatal membranes of rat brain.
    Fujita N; Saito K; Yonehara N; Watanabe Y; Yoshida H
    Life Sci; 1979 Sep; 25(11):969-73. PubMed ID: 513944
    [No Abstract]   [Full Text] [Related]  

  • 34. Differentiation of the central dopaminergic stimulants apomorphine and lergotrile.
    Wade RL; Krewsun I; Quock RM
    Proc West Pharmacol Soc; 1979; 22():141-2. PubMed ID: 42079
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of apomorphine enantiomers and of lisuride on 3,4-dihydroxyphenylalanine production in striatal synaptosomes.
    Bräutigam M; Kittner B; Laschinski G
    Mol Pharmacol; 1985 Dec; 28(6):515-20. PubMed ID: 3935908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of terguride, an ergot alkaloid derivative, on the central nervous system: biochemical and behavioral studies].
    Ikoma Y; Akai T; Nakata Y; Hara K; Wachtel H; Yamaguchi M
    Nihon Yakurigaku Zasshi; 1993 Aug; 102(2):113-29. PubMed ID: 8370555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the dopaminergic effects of apomorphine and (-)-N-n-propylnorapomorphine.
    Menon MK; Clark WG; Neumeyer JL
    Eur J Pharmacol; 1978 Nov; 52(1):1-9. PubMed ID: 569056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of lisuride and LSD on monoamine synthesis after axotomy or reserpine treatment in rat brain.
    Kehr W; Speckenbach W
    Naunyn Schmiedebergs Arch Pharmacol; 1978; 301(3):163-9. PubMed ID: 305542
    [No Abstract]   [Full Text] [Related]  

  • 39. Circling behaviour induced by electrical stimulation of the medial forebrain bundle, importance of stimulus parameters and dopaminergic processes.
    van der Heyden JA
    Pharmacol Biochem Behav; 1984 Oct; 21(4):567-74. PubMed ID: 6334318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of dopamine and serotonin in the discriminative stimulus effects of lisuride.
    White FJ; Appel JB
    J Pharmacol Exp Ther; 1982 May; 221(2):421-7. PubMed ID: 7077537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.